Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.48 USD | -3.11% | -2.34% | +10.08% |
16/04 | BTIG Cuts Price Target on Xencor to $38 From $56, Keeps Buy Rating | MT |
09/04 | Xencor Names Bart Cornelissen as Chief Financial Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.08% | 1.49B | |
+4.05% | 106B | |
+7.02% | 23.47B | |
-14.65% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-10.11% | 16.78B | |
+5.42% | 14.41B | |
+35.25% | 12.86B | |
+325.09% | 8.78B |
- Stock Market
- Equities
- XNCR Stock
- News Xencor, Inc.
- Xencor Says Cancer Drug Candidates Showed Anti-Tumor Activity in Preclinical Trials